1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Innovation Research for Healthcare (AI Solutions) is sponsored by National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH). This SBIR opportunity supports small businesses in any biomedical or behavioral research area within NIH's mission, with a specific focus on AI solutions for medical diagnosis, drug discovery, and clinical decision support.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
U.S. Department of Health & Human Services National Institutes of Health ### NIH Websites Are Changing Get the Latest Updates and FAQs [](http://ncats. nih.
gov/funding/small-business-programs:#) * Small Business Programs * Funding Policies and Considerations * Challenges and Prize Competitions * Challenges and Prize Competitions Winners * Conference Grant Information * Resources for Researchers * Resources for Rare Disease Patients and Advocates * Scientific Publications * About Translational Science **Our apologies. We cannot find the page you’re trying to view.
** It’s possible that the page is temporarily unavailable, has been removed or renamed, or no longer exists. ### What would you like to do now? Here are some other suggestions: * Search for the page by entering keyword(s) in the search field above.
* Use the tabs above to find information you want. * If you typed the page address in the address bar, make sure that you spelled it correctly. Last updated on July 23, 2025 Last updated on July 23, 2025 9609 Medical Center Drive * [](http://www.
facebook. com/ncats. nih.
gov "Visit us on Facebook") * [](https://www. linkedin. com/company/nih-ncats "Visit us on LinkedIn") * [](http://www.
twitter. com/ncats_nih_gov "Visit us on X") * [](http://www. youtube.
com/user/ncatsmedia "View our videos on YouTube") For language access assistance, contact the NCATS Public Information Officer
According to the current listing, eligibility includes: Small businesses engaged in biomedical or behavioral research; small businesses focusing on AI solutions for medical diagnosis, drug discovery, and clinical decision support. Confirm the full requirements in the official notice before applying.
Small Business Innovation Research for Healthcare (AI Solutions) is funded by National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) (PAR-25-195) is sponsored by National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH). This limited-competition grant supports institutional postdoctoral research training and career development programs in clinical and translational science.
Clinical Trials on a Chip is sponsored by National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH). This program supports researchers using tiny, bioengineered models of human tissues and organ systems (tissue chips/organoids) to study diseases and test drugs, with the goal of improving clinical trial design and implementation. Adipose organoid models could be utilized to develop disease models relevant to metabolic diseases, drug testing, and toxicity assessment.
Advance from NIH SBIR Phase I to Phase II with tips on demonstrating feasibility, building a commercialization plan, and securing $1M in funding.
Read articlePAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read article